Invasive Ductal Carcinoma - Multifocal (USA)

76 year old lady with no symptoms. And these synthetic views would detective around circumscribed mass in the white breast. Yeah, I'm here. If we focus on the turmoil. You could see this lesion. But it was a new mouse. That is why it was suspicious. We perform. An ultrasound guided biopsy and the result was. Invasive ductal cancer luminal a subtype. Colloid cancer. They didn't really view it again, it's almost. And found some additional. Round circumscribed lesions in the same breast. But this time without ultrasound correlation. That is why we perform. A tumor guided biopsy. This is the initial Tomoo acquisition and the acquisition after the biopsy. And the final result was multicentric invasive ductal carcinoma. All of them were mucinous carcinomas. So in this particular case. Tommy guided biopsy was necessary. For these additional additions that were only detected on tomosynthesis.

11 Preoperative 4 Digital Breast Tomosynthesis and Contrast Enhanced Mammography Prof. Dr. Luis Pina Breast Imaging Department (Radiología mamaria) Clínica Universidad de Navarra, Pamplona / Spain SIEMENS 11_PreOp_4, PID3641 * 1/1/2022 F PID3641 Series Navigator INSIGHT_2D Add Study PID3641 11/1/2021 (Study date) Prior 02 MG, 12/1/2021 n.a ., 4 mon ... Biopsia Mama Esterotaxia RCC TRCCSC Viewing Favorite Layouts US MR DYN MR.Dyna ... IN 2D ReportFlow MR.Empty BASIC Printing Tools Findings MR 5:42 PM C.US | C .... Clinical information 76-year-old female Asymptomatic Healthineers LCC RMLO LMLO Slice 21 / 54 Slice 14 / 54 Slice 14 / 66 Slice thickness: 1.00 mm Prior 02 Prior 02 SIEMENS . Pathology Invasive ductal carcinoma (IDC) Luminal A TRCC Slice 14/ 54 C.CC Prior 01 Slice 40 / 77 Multicentric invasive ductal carcinoma (IDC) Luminal A, mucinous carcinoma Conclusion Tomoguided biopsy is necessary for lesions only detected on DBT. Siemens Healthcare GmbH, 2022 Sometimes IN2D images (= synthetic mammograms) are shown while verbally referring to the conventional mammograms. The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed. Results from case studies are not predictive of results in other cases. Results in other cases may vary. The statements by Siemens' customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" setting and many variables exist (e.g ., hospital size, samples mix, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results. Dr. Luis Pina is employed by an institution that receives financial support from Siemens Healthineers for collaborations.